Analytical services

Identification, Development, Monitoring and Quality Control Testing of your Product

All of Upperton’s Development and Manufacturing Services are underpinned by our experienced analytical team and capabilities.

Our scientist know that the success of all projects begins with a solid understanding of your API’s physio chemical characteristics and working in conjunction with our formulators we work to ensure the early identification of lead prototype formulations suitable for clinical testing followed by the development of suitable methods for the monitoring of your product through the development cycle.

Research and Development

Using a range of techniques including, DSC / TGA, XRPD, Microscopy, FTIR, Particle sizing. etc. we gain fundamental understanding and insight into the behaviours and of your API and support the development activities required to support First in Human studies and product development.

Material Identification
Solubility Screening
Excipient Compatibility
Physio Chemical characterisation
Support or enabling protocols UpperSolv™, PulmoCraft™ and UpperNose™

Stability Testing (ASAPprime® )

Early data read outs on the stability of both the API and early formulations can be used to provide early indications on potential stability issues, vital information that can save time and money in the development pathway. ASAPprime^® has been incorporated into our development programme as a critical, early stage analytical tool for identifying potential stability issues

Analytical and QC Services

Once your product enters clinical development our dedicated team of analytical experts work with you and our cross functional teams to transfer, development, and phase appropriate validation of your analytical methods and performance of QC and release testing including: